Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder ...Middle East

Brixadi is the first treatment for opioid use disorder in the US with both weekly and monthly dosing Three million people in the US diagnosed with opioid use disorder LUND, Sweden, May 24, 2023 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announces that the US Food and Drug...

Hence then, the article about camurus announces fda approval of brixadi for the treatment of moderate to severe opioid use disorder was published today ( Wednesday 24/05/2023 - 06:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder )

Also on site :

• ‘Free Bert’ Review: Bert Kreischer Strips Away the Shirtless Party Boy Persona, but Also the Laughs, in New Netflix Comedy
• ‘90s Alt-Rock Icon Announces First Show of the Year in California
• NYT Connections Sports Edition Today: Hints and Answers for Thursday, January 22, 2026